ArticleTranslational cancer research2025

Microsatellite instability (MSI) and the tumor mutation burden (TMB) as biomarkers of response to immune checkpoint inhibitors in prostate cancer.

Ioannis A VoutsadakisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.